Similar articles

• Trial of an oral antigen in upper respiratory tract infections in two Bristol schools.

  Price HC, Henley G. Price HC, et al. Practitioner. 1974 Nov;213(1277):720-6. Practitioner. 1974. PMID: 4617212 Clinical Trial. No abstract available.
• [Efficacy of a polyvalent bacterial vaccine administered by aerosol in the treatment of children with respiratory infections].

  Vascotto M, Fossi E, Mancini E, Guerrini L. Vascotto M, et al. Minerva Pediatr. 1985 May 31;37(10):409-14. Minerva Pediatr. 1985. PMID: 4047012 Italian. No abstract available.
• Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels.

  Rossi GA, Peri C, Raynal ME, Defilippi AC, Risso FM, Schenone G, Pallestrini E, Melioli G. Rossi GA, et al. Immunol Lett. 2003 Mar 3;86(1):85-91. doi: 10.1016/s0165-2478(02)00290-0. Immunol Lett. 2003. PMID: 12600750
• Mucosal vaccination against bacterial respiratory infections.

  Baumann U. Baumann U. Expert Rev Vaccines. 2008 Oct;7(8):1257-76. doi: 10.1586/14760584.7.8.1257. Expert Rev Vaccines. 2008. PMID: 18844598 Review.
• Intranasal vaccines for protection against respiratory and systemic bacterial infections.

  Oliveira ML, Arêas AP, Ho PL. Oliveira ML, et al. Expert Rev Vaccines. 2007 Jun;6(3):419-29. doi: 10.1586/14760584.6.3.419. Expert Rev Vaccines. 2007. PMID: 17542756 Review.